These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11449081)

  • 21. Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial.
    Chlebowski RT; Anderson GL; Sarto GE; Haque R; Runowicz CD; Aragaki AK; Thomson CA; Howard BV; Wactawski-Wende J; Chen C; Rohan TE; Simon MS; Reed SD; Manson JE
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26668177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HRT: some unresolved clinical issues in breast cancer, endometrial cancer and premature ovarian insufficiency.
    Davey DA
    Womens Health (Lond); 2013 Jan; 9(1):59-67. PubMed ID: 23241155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
    Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
    JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of HRT and the subsequent risk of cancer.
    Beral V; Banks E; Reeves G; Appleby P
    J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Indications for hormone replacement therapy].
    Birkhäuser MH
    Ther Umsch; 2000 Oct; 57(10):635-42. PubMed ID: 11081375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies to reduce the incidence of endometrial cancer in postmenopausal women.
    Gambrell RD
    Am J Obstet Gynecol; 1997 Nov; 177(5):1196-204; discussion 1204-7. PubMed ID: 9396919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?
    Trabert B; Wentzensen N; Yang HP; Sherman ME; Hollenbeck AR; Park Y; Brinton LA
    Int J Cancer; 2013 Jan; 132(2):417-26. PubMed ID: 22553145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are progestins really necessary as part of a combined HRT regimen?
    Sturdee DW
    Climacteric; 2013 Aug; 16 Suppl 1():79-84. PubMed ID: 23651281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endometrial cancer and hormone replacement therapy. Appropriate use of progestins to oppose endogenous and exogenous estrogen.
    Sulak PJ
    Endocrinol Metab Clin North Am; 1997 Jun; 26(2):399-412. PubMed ID: 9193892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormone replacement therapy and the risk of endometrial cancer: A systematic review.
    Sjögren LL; Mørch LS; Løkkegaard E
    Maturitas; 2016 Sep; 91():25-35. PubMed ID: 27451318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postmenopausal hormone replacement therapy use and risk of endometrial cancer in Japanese women.
    Mizunuma H; Honjo H; Aso T; Urabe M; Ohta H; Kobayashi S; Sagara Y; Sanada M; Tanaka K; Dobashi K; Hayashi K; Ohama K
    Climacteric; 2001 Dec; 4(4):293-8. PubMed ID: 11770185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of the endometrial effects of estrogens and progestins.
    Creasy GW; Kafrissen ME; Upmalis D
    Obstet Gynecol Surv; 1992 Sep; 47(9):654-78. PubMed ID: 1436909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endometrial cancer in postmenopausal women using estradiol-progestin therapy.
    Jaakkola S; Lyytinen H; Pukkala E; Ylikorkala O
    Obstet Gynecol; 2009 Dec; 114(6):1197-1204. PubMed ID: 19935019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Balancing safety and efficacy focus on endometrial protection.
    Boroditsky RS
    J Reprod Med; 2000 Mar; 45(3 Suppl):273-84. PubMed ID: 10756508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postmenopausal vaginal bleeding in women using hormone replacement therapy.
    Burbos N; Musonda P; Duncan TJ; Crocker SG; Nieto JJ; Morris EP
    Menopause Int; 2012 Mar; 18(1):5-9. PubMed ID: 22323674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormone replacement therapy and endometrial cancer risk: a meta-analysis.
    Grady D; Gebretsadik T; Kerlikowske K; Ernster V; Petitti D
    Obstet Gynecol; 1995 Feb; 85(2):304-13. PubMed ID: 7824251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoplasia of the female reproductive tract: effects of hormone therapy.
    Archer DF
    Endocrine; 2004 Aug; 24(3):259-63. PubMed ID: 15542895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postmenopausal estrogens and progestogens and the incidence of gynecologic cancer.
    Weiss NS; Hill DA
    Maturitas; 1996 Mar; 23(2):235-9. PubMed ID: 8735361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does HRT modify risk of gynecological cancers?
    Schneider HP; Birkhauser M
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():40-53. PubMed ID: 7581588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Links between hormone replacement therapy and neoplasia.
    Hulka BS
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):168S-175S. PubMed ID: 7958013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.